FDA.reportPublic FDA data

AVEDA SCALP REMEDY DADRUFF

Manufacturer
Aveda Corporation | Estee Lauder Companies Inc. | Marietta Corporation dba Voyant Beauty
Effective date
2023-07-27
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
legacy-cache
Hydrated at
2026-08-01 21:22:26

Label at a glance#

ProductAVEDA SCALP REMEDY DADRUFF
Active ingredientSALICYLIC ACID
Label structure7 sections

Dosage and administration

■ Apply to affected areas 2 to 4 times daily or as directed by a doctor. ■ Do not rinse out.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2.0%

Purpose

OTC - PURPOSE SECTION

Anti-dandruff

USE

INDICATIONS & USAGE SECTION

helps eliminate flaking and irritation

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

do not get into eyes. If contact occurs,
rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens or does not
improve after regular use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical
help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

■ Apply to affected areas 2 to 4 times daily or as
directed by a doctor. ■ Do not rinse out.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Water\Aqua\Eau, Alcohol Denat., Betaine,
Sodium Methyl Cocoyl Taurate, Lippia Sidoides (Oregano) Leaf Oil,
Rosmarinus Officinalis (Rosemary) Leaf Extract,
Echinacea Purpurea (Coneflower) Extract, Arctium
Lappa (Burdock) Root Extract, Salvia Officinalis
(Sage) Leaf Extract, Narcissus Tazetta Bulb Extract,
Glycerin, Dimethicone PEG-8 Meadowfoamate,
Hydroxyethylcellulose, Fragrance (Parfum), Eugenol,
Linalool, Citral, Limonene, Sodium Citrate, Sodium
Chloride <ILN45198>

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

AVEDA
Scalp Remedy
DANDRUFF SOLUTION
helps eliminate flaking and irritation
4.2 fl oz/oz liq/125 ml e PDPPDP

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
57677-065-012023-11-03C16284748780-10191ceaa-69a2-198a-e063-dbdaa90aec3eef2c4a93-864b-f147-e053-2995a90ae207
57677-065-012023-07-28C16284748780-10191ceaa-69a2-198a-e063-dbdaa90aec3eef2c4a93-864b-f147-e053-2995a90ae207

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
57677-06557677-065-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Name, UNII, Kind table
NameUNIIKind
LIPPIA SIDOIDES LEAF OILM86P9S87MRIACT
CITRALT7EU0O9VPPIACT
SODIUM CITRATE1Q73Q2JULRIACT
SODIUM CHLORIDE451W47IQ8XIACT
NARCISSUS TAZETTA BULBK17762966SIACT
WATER059QF0KO0RIACT
ALCOHOL3K9958V90MIACT
ECHINACEA PURPUREAQI7G114Y98IACT
ARCTIUM LAPPA ROOT597E9BI3Z3IACT
SAGE065C5D077JIACT
GLYCERINPDC6A3C0OXIACT
HYDROXYETHYL CELLULOSE, UNSPECIFIEDT4V6TWG28DIACT
EUGENOL3T8H1794QWIACT
LINALOOL, (+/-)-D81QY6I88EIACT
LIMONENE, (+)-GFD7C86Q1WIACT
SALICYLIC ACIDO414PZ4LPZACTIB
BETAINE3SCV180C9WIACT
SODIUM METHYL COCOYL TAURATEJVL98CG53GIACT
ROSEMARYIJ67X351P9IACT
DIMETHICONE PEG-8 MEADOWFOAMATE53UN5B8F4WIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
017aa02e-f8f0-f400-e063-6294a90a4abeef2c4a93-864b-f147-e053-2995a90ae2072023-07-27WarningsExact identifier
spl id: 017aa02e-f8f0-f400-e063-6294a90a4abe
spl set id: ef2c4a93-864b-f147-e053-2995a90ae207

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.